Replies to The Memorial Sloan-Kettering website mentions that 177Lu-PSMA-617 was FDA-approved in March 2022.

Discussion

Prostate Cancer | Last Active: Feb 16, 2023 | Replies (11)

Comment receiving replies

@lferrydennis

The Memorial Sloan-Kettering website mentions that 177Lu-PSMA-617 was FDA-approved in March 2022.

Replies to "The Memorial Sloan-Kettering website mentions that 177Lu-PSMA-617 was FDA-approved in March 2022."

firespooks | @firespooks | Feb 14, 2023

I was told by my oncologist that you can’t use that medication until the Hormone Therapy quit working.